AGE|AGE_ADJUSTED_CI_LOWER|AGE_ADJUSTED_CI_UPPER|AGE_ADJUSTED_RATE|COUNT|EVENT_TYPE|POPULATION|SITE|YEAR
0-14|3.5|3.8|3.6|1971|Incidence|54648012|Acute Lymphocytic|1999
0-19|2.9|3.2|3.1|2227|Incidence|72909327|Acute Lymphocytic|1999
0-14|0.6|0.8|0.7|376|Incidence|54648012|Acute Myeloid|1999
0-19|0.7|0.8|0.7|536|Incidence|72909327|Acute Myeloid|1999
0-14|14.4|15.0|14.7|8023|Incidence|54648012|All Cancer Sites Combined|1999
0-19|15.8|16.3|16.0|11678|Incidence|72909327|All Cancer Sites Combined|1999
0-14|0.7|0.8|0.8|412|Incidence|54648012|Bones and Joints|1999
0-19|0.8|1.0|0.9|667|Incidence|72909327|Bones and Joints|1999
0-14|3.1|3.4|3.3|1795|Incidence|54648012|Brain and Other Nervous System|1999
0-19|2.9|3.1|3.0|2175|Incidence|72909327|Brain and Other Nervous System|1999
0-14|0.5|0.6|0.5|298|Incidence|54648012|Hodgkin Lymphoma|1999
0-19|1.1|1.3|1.2|878|Incidence|72909327|Hodgkin Lymphoma|1999
0-14|0.8|0.9|0.8|454|Incidence|54648012|Kidney and Renal Pelvis|1999
0-19|0.6|0.7|0.7|481|Incidence|72909327|Kidney and Renal Pelvis|1999
0-14|4.4|4.8|4.6|2524|Incidence|54648012|Leukemia|1999
0-19|4.0|4.3|4.1|3018|Incidence|72909327|Leukemia|1999
0-14|0.8|1.0|0.9|497|Incidence|54648012|Non-Hodgkin Lymphoma|1999
0-19|1.0|1.2|1.1|784|Incidence|72909327|Non-Hodgkin Lymphoma|1999
0-14|2.8|3.1|2.9|1579|Incidence|54648012|Other|1999
0-19|4.0|4.3|4.2|3035|Incidence|72909327|Other|1999
0-14|0.8|0.9|0.9|464|Incidence|54648012|Soft Tissue|1999
0-19|0.8|1.0|0.9|640|Incidence|72909327|Soft Tissue|1999
0-14|3.5|3.8|3.7|2061|Incidence|56294656|Acute Lymphocytic|2000
0-19|3.0|3.3|3.2|2367|Incidence|75211310|Acute Lymphocytic|2000
0-14|0.5|0.7|0.6|333|Incidence|56294656|Acute Myeloid|2000
0-19|0.6|0.7|0.7|488|Incidence|75211310|Acute Myeloid|2000
0-14|14.7|15.3|15.0|8420|Incidence|56294656|All Cancer Sites Combined|2000
0-19|16.1|16.7|16.4|12317|Incidence|75211310|All Cancer Sites Combined|2000
0-14|0.6|0.7|0.7|382|Incidence|56294656|Bones and Joints|2000
0-19|0.8|0.9|0.9|649|Incidence|75211310|Bones and Joints|2000
0-14|3.3|3.6|3.4|1927|Incidence|56294656|Brain and Other Nervous System|2000
0-19|3.0|3.3|3.1|2347|Incidence|75211310|Brain and Other Nervous System|2000
0-14|0.5|0.7|0.6|335|Incidence|56294656|Hodgkin Lymphoma|2000
0-19|1.2|1.3|1.2|929|Incidence|75211310|Hodgkin Lymphoma|2000
0-14|0.8|1.0|0.9|498|Incidence|56294656|Kidney and Renal Pelvis|2000
0-19|0.6|0.8|0.7|523|Incidence|75211310|Kidney and Renal Pelvis|2000
0-14|4.4|4.8|4.6|2586|Incidence|56294656|Leukemia|2000
0-19|4.0|4.3|4.1|3103|Incidence|75211310|Leukemia|2000
0-14|0.9|1.0|0.9|533|Incidence|56294656|Non-Hodgkin Lymphoma|2000
0-19|1.1|1.2|1.2|868|Incidence|75211310|Non-Hodgkin Lymphoma|2000
0-14|2.8|3.0|2.9|1625|Incidence|56294656|Other|2000
0-19|4.0|4.3|4.2|3131|Incidence|75211310|Other|2000
0-14|0.9|1.0|1.0|534|Incidence|56294656|Soft Tissue|2000
0-19|1.0|1.1|1.0|767|Incidence|75211310|Soft Tissue|2000
0-14|3.7|4.0|3.9|2142|Incidence|55815598|Acute Lymphocytic|2001
0-19|3.2|3.4|3.3|2435|Incidence|74693573|Acute Lymphocytic|2001
0-14|0.6|0.8|0.7|381|Incidence|55815598|Acute Myeloid|2001
0-19|0.7|0.8|0.7|537|Incidence|74693573|Acute Myeloid|2001
0-14|15.5|16.1|15.8|8818|Incidence|55815598|All Cancer Sites Combined|2001
0-19|16.9|17.5|17.2|12867|Incidence|74693573|All Cancer Sites Combined|2001
0-14|0.7|0.8|0.7|409|Incidence|55815598|Bones and Joints|2001
0-19|0.9|1.1|1.0|736|Incidence|74693573|Bones and Joints|2001
0-14|3.2|3.5|3.4|1879|Incidence|55815598|Brain and Other Nervous System|2001
0-19|2.9|3.2|3.1|2291|Incidence|74693573|Brain and Other Nervous System|2001
0-14|0.5|0.7|0.6|332|Incidence|55815598|Hodgkin Lymphoma|2001
0-19|1.2|1.3|1.3|951|Incidence|74693573|Hodgkin Lymphoma|2001
0-14|0.8|1.0|0.9|493|Incidence|55815598|Kidney and Renal Pelvis|2001
0-19|0.6|0.8|0.7|523|Incidence|74693573|Kidney and Renal Pelvis|2001
0-14|4.8|5.1|4.9|2743|Incidence|55815598|Leukemia|2001
0-19|4.3|4.6|4.4|3281|Incidence|74693573|Leukemia|2001
0-14|0.9|1.0|0.9|520|Incidence|55815598|Non-Hodgkin Lymphoma|2001
0-19|1.1|1.2|1.1|858|Incidence|74693573|Non-Hodgkin Lymphoma|2001
0-14|3.2|3.5|3.4|1889|Incidence|55815598|Other|2001
0-19|4.5|4.8|4.6|3465|Incidence|74693573|Other|2001
0-14|0.9|1.1|1.0|553|Incidence|55815598|Soft Tissue|2001
0-19|0.9|1.1|1.0|762|Incidence|74693573|Soft Tissue|2001
0-14|3.5|3.8|3.7|2073|Incidence|56622973|Acute Lymphocytic|2002
0-19|3.0|3.3|3.2|2383|Incidence|75875139|Acute Lymphocytic|2002
0-14|0.6|0.7|0.7|385|Incidence|56622973|Acute Myeloid|2002
0-19|0.7|0.8|0.7|552|Incidence|75875139|Acute Myeloid|2002
0-14|15.3|15.9|15.6|8839|Incidence|56622973|All Cancer Sites Combined|2002
0-19|16.9|17.5|17.2|13026|Incidence|75875139|All Cancer Sites Combined|2002
0-14|0.7|0.8|0.7|416|Incidence|56622973|Bones and Joints|2002
0-19|0.9|1.0|0.9|726|Incidence|75875139|Bones and Joints|2002
0-14|3.4|3.7|3.6|2005|Incidence|56622973|Brain and Other Nervous System|2002
0-19|3.1|3.3|3.2|2428|Incidence|75875139|Brain and Other Nervous System|2002
0-14|0.5|0.6|0.5|310|Incidence|56622973|Hodgkin Lymphoma|2002
0-19|1.1|1.3|1.2|934|Incidence|75875139|Hodgkin Lymphoma|2002
0-14|0.8|0.9|0.9|479|Incidence|56622973|Kidney and Renal Pelvis|2002
0-19|0.6|0.7|0.7|504|Incidence|75875139|Kidney and Renal Pelvis|2002
0-14|4.6|5.0|4.8|2692|Incidence|56622973|Leukemia|2002
0-19|4.2|4.4|4.3|3245|Incidence|75875139|Leukemia|2002
0-14|0.8|1.0|0.9|517|Incidence|56622973|Non-Hodgkin Lymphoma|2002
0-19|1.1|1.2|1.1|862|Incidence|75875139|Non-Hodgkin Lymphoma|2002
0-14|3.1|3.4|3.2|1837|Incidence|56622973|Other|2002
0-19|4.5|4.8|4.6|3540|Incidence|75875139|Other|2002
0-14|0.9|1.1|1.0|583|Incidence|56622973|Soft Tissue|2002
0-19|1.0|1.1|1.0|787|Incidence|75875139|Soft Tissue|2002
0-14|3.4|3.7|3.6|2119|Incidence|59442844|Acute Lymphocytic|2003
0-19|2.9|3.2|3.1|2416|Incidence|79843536|Acute Lymphocytic|2003
0-14|0.6|0.7|0.6|388|Incidence|59442844|Acute Myeloid|2003
0-19|0.6|0.7|0.7|550|Incidence|79843536|Acute Myeloid|2003
0-14|14.9|15.5|15.2|9058|Incidence|59442844|All Cancer Sites Combined|2003
0-19|16.4|17.0|16.7|13381|Incidence|79843536|All Cancer Sites Combined|2003
0-14|0.6|0.8|0.7|420|Incidence|59442844|Bones and Joints|2003
0-19|0.8|1.0|0.9|724|Incidence|79843536|Bones and Joints|2003
0-14|3.2|3.5|3.3|1984|Incidence|59442844|Brain and Other Nervous System|2003
0-19|2.9|3.2|3.1|2432|Incidence|79843536|Brain and Other Nervous System|2003
0-14|0.5|0.6|0.6|353|Incidence|59442844|Hodgkin Lymphoma|2003
0-19|1.2|1.3|1.2|1000|Incidence|79843536|Hodgkin Lymphoma|2003
0-14|0.8|1.0|0.9|518|Incidence|59442844|Kidney and Renal Pelvis|2003
0-19|0.6|0.8|0.7|547|Incidence|79843536|Kidney and Renal Pelvis|2003
0-14|4.4|4.7|4.6|2706|Incidence|59442844|Leukemia|2003
0-19|4.0|4.2|4.1|3259|Incidence|79843536|Leukemia|2003
0-14|0.8|1.0|0.9|532|Incidence|59442844|Non-Hodgkin Lymphoma|2003
0-19|1.0|1.2|1.1|861|Incidence|79843536|Non-Hodgkin Lymphoma|2003
0-14|3.2|3.4|3.3|1980|Incidence|59442844|Other|2003
0-19|4.5|4.8|4.6|3746|Incidence|79843536|Other|2003
0-14|0.9|1.0|0.9|565|Incidence|59442844|Soft Tissue|2003
0-19|0.9|1.1|1.0|812|Incidence|79843536|Soft Tissue|2003
0-14|3.7|4.0|3.9|2330|Incidence|60651802|Acute Lymphocytic|2004
0-19|3.2|3.4|3.3|2671|Incidence|81754354|Acute Lymphocytic|2004
0-14|0.6|0.8|0.7|423|Incidence|60651802|Acute Myeloid|2004
0-19|0.7|0.8|0.7|597|Incidence|81754354|Acute Myeloid|2004
0-14|15.6|16.3|15.9|9704|Incidence|60651802|All Cancer Sites Combined|2004
0-19|17.1|17.6|17.3|14246|Incidence|81754354|All Cancer Sites Combined|2004
0-14|0.7|0.8|0.7|448|Incidence|60651802|Bones and Joints|2004
0-19|0.9|1.0|0.9|760|Incidence|81754354|Bones and Joints|2004
0-14|3.4|3.7|3.5|2147|Incidence|60651802|Brain and Other Nervous System|2004
0-19|3.1|3.4|3.2|2635|Incidence|81754354|Brain and Other Nervous System|2004
0-14|0.5|0.6|0.5|324|Incidence|60651802|Hodgkin Lymphoma|2004
0-19|1.1|1.3|1.2|985|Incidence|81754354|Hodgkin Lymphoma|2004
0-14|0.8|0.9|0.8|507|Incidence|60651802|Kidney and Renal Pelvis|2004
0-19|0.6|0.7|0.7|548|Incidence|81754354|Kidney and Renal Pelvis|2004
0-14|4.8|5.1|4.9|2995|Incidence|60651802|Leukemia|2004
0-19|4.3|4.6|4.4|3595|Incidence|81754354|Leukemia|2004
0-14|0.9|1.0|0.9|575|Incidence|60651802|Non-Hodgkin Lymphoma|2004
0-19|1.0|1.2|1.1|918|Incidence|81754354|Non-Hodgkin Lymphoma|2004
0-14|3.3|3.6|3.4|2100|Incidence|60651802|Other|2004
0-19|4.6|4.9|4.8|3947|Incidence|81754354|Other|2004
0-14|0.9|1.1|1.0|608|Incidence|60651802|Soft Tissue|2004
0-19|1.0|1.1|1.0|858|Incidence|81754354|Soft Tissue|2004
0-14|3.6|3.9|3.7|2254|Incidence|60519046|Acute Lymphocytic|2005
0-19|3.1|3.3|3.2|2586|Incidence|82005260|Acute Lymphocytic|2005
0-14|0.6|0.7|0.6|392|Incidence|60519046|Acute Myeloid|2005
0-19|0.6|0.7|0.7|543|Incidence|82005260|Acute Myeloid|2005
0-14|15.2|15.8|15.5|9445|Incidence|60519046|All Cancer Sites Combined|2005
0-19|16.9|17.4|17.2|14180|Incidence|82005260|All Cancer Sites Combined|2005
0-14|0.6|0.8|0.7|420|Incidence|60519046|Bones and Joints|2005
0-19|0.8|1.0|0.9|747|Incidence|82005260|Bones and Joints|2005
0-14|3.2|3.5|3.3|2017|Incidence|60519046|Brain and Other Nervous System|2005
0-19|2.9|3.2|3.0|2485|Incidence|82005260|Brain and Other Nervous System|2005
0-14|0.5|0.7|0.6|360|Incidence|60519046|Hodgkin Lymphoma|2005
0-19|1.2|1.3|1.3|1068|Incidence|82005260|Hodgkin Lymphoma|2005
0-14|0.8|0.9|0.8|516|Incidence|60519046|Kidney and Renal Pelvis|2005
0-19|0.6|0.8|0.7|565|Incidence|82005260|Kidney and Renal Pelvis|2005
0-14|4.6|4.9|4.8|2889|Incidence|60519046|Leukemia|2005
0-19|4.1|4.4|4.2|3478|Incidence|82005260|Leukemia|2005
0-14|0.8|1.0|0.9|560|Incidence|60519046|Non-Hodgkin Lymphoma|2005
0-19|1.1|1.3|1.2|974|Incidence|82005260|Non-Hodgkin Lymphoma|2005
0-14|3.2|3.5|3.4|2075|Incidence|60519046|Other|2005
0-19|4.6|4.9|4.8|4005|Incidence|82005260|Other|2005
0-14|0.9|1.1|1.0|608|Incidence|60519046|Soft Tissue|2005
0-19|1.0|1.1|1.0|858|Incidence|82005260|Soft Tissue|2005
0-14|3.7|4.0|3.9|2340|Incidence|60516709|Acute Lymphocytic|2006
0-19|3.2|3.4|3.3|2696|Incidence|82324418|Acute Lymphocytic|2006
0-14|0.6|0.8|0.7|422|Incidence|60516709|Acute Myeloid|2006
0-19|0.7|0.8|0.7|598|Incidence|82324418|Acute Myeloid|2006
0-14|15.5|16.1|15.8|9607|Incidence|60516709|All Cancer Sites Combined|2006
0-19|16.9|17.4|17.2|14246|Incidence|82324418|All Cancer Sites Combined|2006
0-14|0.7|0.8|0.7|444|Incidence|60516709|Bones and Joints|2006
0-19|0.9|1.0|1.0|796|Incidence|82324418|Bones and Joints|2006
0-14|3.3|3.6|3.5|2090|Incidence|60516709|Brain and Other Nervous System|2006
0-19|3.0|3.3|3.2|2587|Incidence|82324418|Brain and Other Nervous System|2006
0-14|0.6|0.7|0.6|372|Incidence|60516709|Hodgkin Lymphoma|2006
0-19|1.2|1.3|1.2|1051|Incidence|82324418|Hodgkin Lymphoma|2006
0-14|0.8|0.9|0.9|521|Incidence|60516709|Kidney and Renal Pelvis|2006
0-19|0.6|0.8|0.7|568|Incidence|82324418|Kidney and Renal Pelvis|2006
0-14|4.8|5.1|4.9|2998|Incidence|60516709|Leukemia|2006
0-19|4.3|4.6|4.4|3647|Incidence|82324418|Leukemia|2006
0-14|0.8|1.0|0.9|554|Incidence|60516709|Non-Hodgkin Lymphoma|2006
0-19|1.1|1.2|1.1|939|Incidence|82324418|Non-Hodgkin Lymphoma|2006
0-14|3.2|3.5|3.3|2037|Incidence|60516709|Other|2006
0-19|4.4|4.7|4.6|3833|Incidence|82324418|Other|2006
0-14|0.9|1.0|1.0|591|Incidence|60516709|Soft Tissue|2006
0-19|0.9|1.1|1.0|825|Incidence|82324418|Soft Tissue|2006
0-14|3.8|4.1|4.0|2418|Incidence|60681615|Acute Lymphocytic|2007
0-19|3.3|3.5|3.4|2789|Incidence|82749431|Acute Lymphocytic|2007
0-14|0.6|0.7|0.7|410|Incidence|60681615|Acute Myeloid|2007
0-19|0.6|0.8|0.7|580|Incidence|82749431|Acute Myeloid|2007
0-14|15.8|16.4|16.1|9836|Incidence|60681615|All Cancer Sites Combined|2007
0-19|17.3|17.8|17.5|14659|Incidence|82749431|All Cancer Sites Combined|2007
0-14|0.6|0.8|0.7|423|Incidence|60681615|Bones and Joints|2007
0-19|0.8|1.0|0.9|744|Incidence|82749431|Bones and Joints|2007
0-14|3.4|3.7|3.6|2175|Incidence|60681615|Brain and Other Nervous System|2007
0-19|3.1|3.4|3.2|2666|Incidence|82749431|Brain and Other Nervous System|2007
0-14|0.5|0.6|0.5|329|Incidence|60681615|Hodgkin Lymphoma|2007
0-19|1.1|1.3|1.2|1033|Incidence|82749431|Hodgkin Lymphoma|2007
0-14|0.8|1.0|0.9|540|Incidence|60681615|Kidney and Renal Pelvis|2007
0-19|0.7|0.8|0.7|583|Incidence|82749431|Kidney and Renal Pelvis|2007
0-14|4.8|5.2|5.0|3055|Incidence|60681615|Leukemia|2007
0-19|4.3|4.6|4.5|3705|Incidence|82749431|Leukemia|2007
0-14|0.9|1.1|1.0|595|Incidence|60681615|Non-Hodgkin Lymphoma|2007
0-19|1.1|1.2|1.2|970|Incidence|82749431|Non-Hodgkin Lymphoma|2007
0-14|3.2|3.5|3.4|2074|Incidence|60681615|Other|2007
0-19|4.6|4.9|4.8|4046|Incidence|82749431|Other|2007
0-14|1.0|1.1|1.0|645|Incidence|60681615|Soft Tissue|2007
0-19|1.0|1.2|1.1|912|Incidence|82749431|Soft Tissue|2007
0-14|4.0|4.1|4.0|12274|Incidence|302299456|Acute Lymphocytic|2007-2011
0-19|3.4|3.5|3.4|14025|Incidence|411503198|Acute Lymphocytic|2007-2011
0-14|0.6|0.7|0.7|2055|Incidence|302299456|Acute Myeloid|2007-2011
0-19|0.7|0.7|0.7|2965|Incidence|411503198|Acute Myeloid|2007-2011
0-14|16.2|16.5|16.4|49789|Incidence|302299456|All Cancer Sites Combined|2007-2011
0-19|17.6|17.9|17.7|73511|Incidence|411503198|All Cancer Sites Combined|2007-2011
0-14|0.7|0.7|0.7|2124|Incidence|302299456|Bones and Joints|2007-2011
0-19|0.9|0.9|0.9|3661|Incidence|411503198|Bones and Joints|2007-2011
0-14|3.5|3.6|3.5|10749|Incidence|302299456|Brain and Other Nervous System|2007-2011
0-19|3.2|3.3|3.2|13205|Incidence|411503198|Brain and Other Nervous System|2007-2011
0-14|0.5|0.6|0.6|1672|Incidence|302299456|Hodgkin Lymphoma|2007-2011
0-19|1.2|1.3|1.2|5184|Incidence|411503198|Hodgkin Lymphoma|2007-2011
0-14|0.9|0.9|0.9|2782|Incidence|302299456|Kidney and Renal Pelvis|2007-2011
0-19|0.7|0.8|0.7|2990|Incidence|411503198|Kidney and Renal Pelvis|2007-2011
0-14|5.0|5.1|5.1|15411|Incidence|302299456|Leukemia|2007-2011
0-19|4.5|4.6|4.5|18573|Incidence|411503198|Leukemia|2007-2011
0-14|0.9|1.0|1.0|2876|Incidence|302299456|Non-Hodgkin Lymphoma|2007-2011
0-19|1.1|1.2|1.1|4714|Incidence|411503198|Non-Hodgkin Lymphoma|2007-2011
0-14|3.5|3.7|3.6|10997|Incidence|302299456|Other|2007-2011
0-19|4.9|5.0|4.9|20771|Incidence|411503198|Other|2007-2011
0-14|1.0|1.1|1.0|3178|Incidence|302299456|Soft Tissue|2007-2011
0-19|1.0|1.1|1.1|4413|Incidence|411503198|Soft Tissue|2007-2011
0-14|3.9|4.2|4.1|2490|Incidence|60907384|Acute Lymphocytic|2008
0-19|3.3|3.6|3.5|2862|Incidence|83118264|Acute Lymphocytic|2008
0-14|0.6|0.8|0.7|438|Incidence|60907384|Acute Myeloid|2008
0-19|0.7|0.8|0.7|624|Incidence|83118264|Acute Myeloid|2008
0-14|16.0|16.6|16.3|10008|Incidence|60907384|All Cancer Sites Combined|2008
0-19|17.4|18.0|17.7|14856|Incidence|83118264|All Cancer Sites Combined|2008
0-14|0.6|0.8|0.7|421|Incidence|60907384|Bones and Joints|2008
0-19|0.8|1.0|0.9|743|Incidence|83118264|Bones and Joints|2008
0-14|3.4|3.7|3.6|2173|Incidence|60907384|Brain and Other Nervous System|2008
0-19|3.1|3.4|3.2|2682|Incidence|83118264|Brain and Other Nervous System|2008
0-14|0.6|0.7|0.6|379|Incidence|60907384|Hodgkin Lymphoma|2008
0-19|1.2|1.4|1.3|1099|Incidence|83118264|Hodgkin Lymphoma|2008
0-14|0.8|1.0|0.9|569|Incidence|60907384|Kidney and Renal Pelvis|2008
0-19|0.7|0.8|0.7|618|Incidence|83118264|Kidney and Renal Pelvis|2008
0-14|5.0|5.3|5.1|3153|Incidence|60907384|Leukemia|2008
0-19|4.4|4.7|4.6|3810|Incidence|83118264|Leukemia|2008
0-14|0.9|1.0|1.0|579|Incidence|60907384|Non-Hodgkin Lymphoma|2008
0-19|1.1|1.2|1.1|963|Incidence|83118264|Non-Hodgkin Lymphoma|2008
0-14|3.2|3.5|3.3|2072|Incidence|60907384|Other|2008
0-19|4.6|4.9|4.7|4032|Incidence|83118264|Other|2008
0-14|1.0|1.2|1.1|662|Incidence|60907384|Soft Tissue|2008
0-19|1.0|1.2|1.1|909|Incidence|83118264|Soft Tissue|2008
0-14|3.9|4.2|4.0|2490|Incidence|61087581|Acute Lymphocytic|2009
0-19|3.3|3.5|3.4|2840|Incidence|83280391|Acute Lymphocytic|2009
0-14|0.6|0.7|0.7|401|Incidence|61087581|Acute Myeloid|2009
0-19|0.6|0.7|0.7|579|Incidence|83280391|Acute Myeloid|2009
0-14|15.8|16.5|16.1|9913|Incidence|61087581|All Cancer Sites Combined|2009
0-19|17.3|17.9|17.6|14767|Incidence|83280391|All Cancer Sites Combined|2009
0-14|0.6|0.8|0.7|429|Incidence|61087581|Bones and Joints|2009
0-19|0.8|1.0|0.9|758|Incidence|83280391|Bones and Joints|2009
0-14|3.4|3.7|3.5|2149|Incidence|61087581|Brain and Other Nervous System|2009
0-19|3.1|3.3|3.2|2634|Incidence|83280391|Brain and Other Nervous System|2009
0-14|0.5|0.6|0.6|346|Incidence|61087581|Hodgkin Lymphoma|2009
0-19|1.2|1.3|1.3|1073|Incidence|83280391|Hodgkin Lymphoma|2009
0-14|0.9|1.0|0.9|587|Incidence|61087581|Kidney and Renal Pelvis|2009
0-19|0.7|0.8|0.8|630|Incidence|83280391|Kidney and Renal Pelvis|2009
0-14|4.9|5.2|5.0|3102|Incidence|61087581|Leukemia|2009
0-19|4.3|4.6|4.5|3725|Incidence|83280391|Leukemia|2009
0-14|0.9|1.0|0.9|575|Incidence|61087581|Non-Hodgkin Lymphoma|2009
0-19|1.1|1.2|1.1|947|Incidence|83280391|Non-Hodgkin Lymphoma|2009
0-14|3.2|3.5|3.4|2082|Incidence|61087581|Other|2009
0-19|4.7|4.9|4.8|4086|Incidence|83280391|Other|2009
0-14|1.0|1.1|1.0|643|Incidence|61087581|Soft Tissue|2009
0-19|1.0|1.2|1.1|914|Incidence|83280391|Soft Tissue|2009
0-14|3.9|4.2|4.0|2496|Incidence|61201748|Acute Lymphocytic|2010
0-19|3.3|3.5|3.4|2818|Incidence|83180982|Acute Lymphocytic|2010
0-14|0.6|0.7|0.7|412|Incidence|61201748|Acute Myeloid|2010
0-19|0.7|0.8|0.7|606|Incidence|83180982|Acute Myeloid|2010
0-14|16.4|17.1|16.7|10287|Incidence|61201748|All Cancer Sites Combined|2010
0-19|17.6|18.1|17.8|14942|Incidence|83180982|All Cancer Sites Combined|2010
0-14|0.6|0.8|0.7|415|Incidence|61201748|Bones and Joints|2010
0-19|0.8|0.9|0.8|700|Incidence|83180982|Bones and Joints|2010
0-14|3.4|3.7|3.6|2190|Incidence|61201748|Brain and Other Nervous System|2010
0-19|3.1|3.3|3.2|2648|Incidence|83180982|Brain and Other Nervous System|2010
0-14|0.5|0.6|0.5|321|Incidence|61201748|Hodgkin Lymphoma|2010
0-19|1.1|1.3|1.2|1017|Incidence|83180982|Hodgkin Lymphoma|2010
0-14|0.8|0.9|0.9|540|Incidence|61201748|Kidney and Renal Pelvis|2010
0-19|0.6|0.7|0.7|572|Incidence|83180982|Kidney and Renal Pelvis|2010
0-14|4.9|5.3|5.1|3127|Incidence|61201748|Leukemia|2010
0-19|4.4|4.7|4.5|3750|Incidence|83180982|Leukemia|2010
0-14|0.9|1.1|1.0|598|Incidence|61201748|Non-Hodgkin Lymphoma|2010
0-19|1.1|1.2|1.1|953|Incidence|83180982|Non-Hodgkin Lymphoma|2010
0-14|3.8|4.1|4.0|2448|Incidence|61201748|Other|2010
0-19|5.1|5.4|5.2|4411|Incidence|83180982|Other|2010
0-14|1.0|1.1|1.1|648|Incidence|61201748|Soft Tissue|2010
0-19|1.0|1.1|1.1|891|Incidence|83180982|Soft Tissue|2010
0-14|3.9|4.2|4.1|2472|Incidence|60623890|Acute Lymphocytic|2011
0-19|3.3|3.6|3.4|2828|Incidence|82095288|Acute Lymphocytic|2011
0-14|0.6|0.7|0.7|410|Incidence|60623890|Acute Myeloid|2011
0-19|0.7|0.8|0.7|603|Incidence|82095288|Acute Myeloid|2011
0-14|16.2|16.9|16.5|10063|Incidence|60623890|All Cancer Sites Combined|2011
0-19|17.6|18.2|17.9|14754|Incidence|82095288|All Cancer Sites Combined|2011
0-14|0.7|0.8|0.7|449|Incidence|60623890|Bones and Joints|2011
0-19|0.8|1.0|0.9|736|Incidence|82095288|Bones and Joints|2011
0-14|3.3|3.6|3.5|2112|Incidence|60623890|Brain and Other Nervous System|2011
0-19|3.1|3.3|3.2|2637|Incidence|82095288|Brain and Other Nervous System|2011
0-14|0.5|0.6|0.5|311|Incidence|60623890|Hodgkin Lymphoma|2011
0-19|1.1|1.3|1.2|985|Incidence|82095288|Hodgkin Lymphoma|2011
0-14|0.9|1.0|0.9|568|Incidence|60623890|Kidney and Renal Pelvis|2011
0-19|0.7|0.8|0.7|610|Incidence|82095288|Kidney and Renal Pelvis|2011
0-14|4.9|5.3|5.1|3094|Incidence|60623890|Leukemia|2011
0-19|4.4|4.7|4.5|3736|Incidence|82095288|Leukemia|2011
0-14|0.8|1.0|0.9|553|Incidence|60623890|Non-Hodgkin Lymphoma|2011
0-19|1.0|1.2|1.1|917|Incidence|82095288|Non-Hodgkin Lymphoma|2011
0-14|3.7|4.1|3.9|2377|Incidence|60623890|Other|2011
0-19|5.0|5.3|5.2|4318|Incidence|82095288|Other|2011
0-14|0.9|1.1|1.0|599|Incidence|60623890|Soft Tissue|2011
0-19|0.9|1.1|1.0|815|Incidence|82095288|Soft Tissue|2011
0-14|0.3|0.4|0.3|194|Mortality|59955368|Acute Lymphocytic|1999
0-19|0.3|0.4|0.4|285|Mortality|80039970|Acute Lymphocytic|1999
0-14|0.2|0.3|0.2|141|Mortality|59955368|Acute Myeloid|1999
0-19|0.2|0.3|0.3|207|Mortality|80039970|Acute Myeloid|1999
0-14|2.4|2.6|2.5|1498|Mortality|59955368|All Cancer Sites Combined|1999
0-19|2.7|2.9|2.8|2243|Mortality|80039970|All Cancer Sites Combined|1999
0-14|0.1|0.2|0.1|82|Mortality|59955368|Bones and Joints|1999
0-19|0.2|0.3|0.3|209|Mortality|80039970|Bones and Joints|1999
0-14|0.7|0.8|0.7|431|Mortality|59955368|Brain and Other Nervous System|1999
0-19|0.6|0.7|0.7|546|Mortality|80039970|Brain and Other Nervous System|1999
0-14|~|~|~|~|Mortality|59955368|Hodgkin Lymphoma|1999
0-19|0.0|0.1|0.1|41|Mortality|80039970|Hodgkin Lymphoma|1999
0-14|0.1|0.1|0.1|54|Mortality|59955368|Kidney and Renal Pelvis|1999
0-19|0.1|0.1|0.1|62|Mortality|80039970|Kidney and Renal Pelvis|1999
0-14|0.7|0.8|0.8|451|Mortality|59955368|Leukemia|1999
0-19|0.8|0.9|0.8|672|Mortality|80039970|Leukemia|1999
0-14|0.1|0.1|0.1|55|Mortality|59955368|Non-Hodgkin Lymphoma|1999
0-19|0.1|0.2|0.1|106|Mortality|80039970|Non-Hodgkin Lymphoma|1999
0-14|0.5|0.6|0.5|328|Mortality|59955368|Other|1999
0-19|0.5|0.6|0.6|455|Mortality|80039970|Other|1999
0-14|0.1|0.2|0.1|87|Mortality|59955368|Soft Tissue|1999
0-19|0.2|0.2|0.2|152|Mortality|80039970|Soft Tissue|1999
0-14|0.3|0.4|0.4|234|Mortality|60279841|Acute Lymphocytic|2000
0-19|0.4|0.5|0.4|332|Mortality|80574796|Acute Lymphocytic|2000
0-14|0.2|0.3|0.2|145|Mortality|60279841|Acute Myeloid|2000
0-19|0.2|0.3|0.3|222|Mortality|80574796|Acute Myeloid|2000
0-14|2.4|2.7|2.5|1526|Mortality|60279841|All Cancer Sites Combined|2000
0-19|2.7|2.9|2.8|2271|Mortality|80574796|All Cancer Sites Combined|2000
0-14|0.1|0.2|0.1|83|Mortality|60279841|Bones and Joints|2000
0-19|0.2|0.3|0.2|181|Mortality|80574796|Bones and Joints|2000
0-14|0.7|0.8|0.7|440|Mortality|60279841|Brain and Other Nervous System|2000
0-19|0.6|0.7|0.7|545|Mortality|80574796|Brain and Other Nervous System|2000
0-14|~|~|~|~|Mortality|60279841|Hodgkin Lymphoma|2000
0-19|0.0|0.1|0.0|29|Mortality|80574796|Hodgkin Lymphoma|2000
0-14|0.1|0.1|0.1|46|Mortality|60279841|Kidney and Renal Pelvis|2000
0-19|0.1|0.1|0.1|54|Mortality|80574796|Kidney and Renal Pelvis|2000
0-14|0.7|0.9|0.8|490|Mortality|60279841|Leukemia|2000
0-19|0.8|1.0|0.9|732|Mortality|80574796|Leukemia|2000
0-14|0.1|0.1|0.1|55|Mortality|60279841|Non-Hodgkin Lymphoma|2000
0-19|0.1|0.2|0.1|115|Mortality|80574796|Non-Hodgkin Lymphoma|2000
0-14|0.5|0.6|0.6|333|Mortality|60279841|Other|2000
0-19|0.5|0.6|0.6|471|Mortality|80574796|Other|2000
0-14|0.1|0.1|0.1|71|Mortality|60279841|Soft Tissue|2000
0-19|0.2|0.2|0.2|144|Mortality|80574796|Soft Tissue|2000
0-14|0.3|0.4|0.3|208|Mortality|60450257|Acute Lymphocytic|2001
0-19|0.3|0.4|0.4|313|Mortality|80906541|Acute Lymphocytic|2001
0-14|0.2|0.3|0.3|157|Mortality|60450257|Acute Myeloid|2001
0-19|0.2|0.3|0.3|227|Mortality|80906541|Acute Myeloid|2001
0-14|2.4|2.6|2.5|1494|Mortality|60450257|All Cancer Sites Combined|2001
0-19|2.6|2.9|2.8|2226|Mortality|80906541|All Cancer Sites Combined|2001
0-14|0.1|0.2|0.1|88|Mortality|60450257|Bones and Joints|2001
0-19|0.2|0.3|0.2|189|Mortality|80906541|Bones and Joints|2001
0-14|0.6|0.8|0.7|416|Mortality|60450257|Brain and Other Nervous System|2001
0-19|0.6|0.7|0.6|520|Mortality|80906541|Brain and Other Nervous System|2001
0-14|~|~|~|~|Mortality|60450257|Hodgkin Lymphoma|2001
0-19|0.0|0.1|0.0|31|Mortality|80906541|Hodgkin Lymphoma|2001
0-14|0.1|0.1|0.1|58|Mortality|60450257|Kidney and Renal Pelvis|2001
0-19|0.1|0.1|0.1|66|Mortality|80906541|Kidney and Renal Pelvis|2001
0-14|0.8|0.9|0.8|503|Mortality|60450257|Leukemia|2001
0-19|0.8|1.0|0.9|728|Mortality|80906541|Leukemia|2001
0-14|0.0|0.1|0.1|40|Mortality|60450257|Non-Hodgkin Lymphoma|2001
0-19|0.1|0.2|0.1|101|Mortality|80906541|Non-Hodgkin Lymphoma|2001
0-14|0.4|0.6|0.5|297|Mortality|60450257|Other|2001
0-19|0.5|0.6|0.6|444|Mortality|80906541|Other|2001
0-14|0.1|0.2|0.1|86|Mortality|60450257|Soft Tissue|2001
0-19|0.2|0.2|0.2|147|Mortality|80906541|Soft Tissue|2001
0-14|0.3|0.4|0.4|217|Mortality|60563030|Acute Lymphocytic|2002
0-19|0.4|0.4|0.4|323|Mortality|81173400|Acute Lymphocytic|2002
0-14|0.2|0.3|0.2|131|Mortality|60563030|Acute Myeloid|2002
0-19|0.2|0.3|0.3|209|Mortality|81173400|Acute Myeloid|2002
0-14|2.4|2.7|2.6|1548|Mortality|60563030|All Cancer Sites Combined|2002
0-19|2.7|2.9|2.8|2271|Mortality|81173400|All Cancer Sites Combined|2002
0-14|0.1|0.2|0.1|85|Mortality|60563030|Bones and Joints|2002
0-19|0.2|0.3|0.2|179|Mortality|81173400|Bones and Joints|2002
0-14|0.7|0.8|0.8|463|Mortality|60563030|Brain and Other Nervous System|2002
0-19|0.7|0.8|0.7|571|Mortality|81173400|Brain and Other Nervous System|2002
0-14|~|~|~|~|Mortality|60563030|Hodgkin Lymphoma|2002
0-19|0.0|0.1|0.0|33|Mortality|81173400|Hodgkin Lymphoma|2002
0-14|0.1|0.1|0.1|42|Mortality|60563030|Kidney and Renal Pelvis|2002
0-19|0.0|0.1|0.1|49|Mortality|81173400|Kidney and Renal Pelvis|2002
0-14|0.7|0.8|0.7|441|Mortality|60563030|Leukemia|2002
0-19|0.8|0.9|0.8|678|Mortality|81173400|Leukemia|2002
0-14|0.1|0.2|0.1|74|Mortality|60563030|Non-Hodgkin Lymphoma|2002
0-19|0.1|0.2|0.1|118|Mortality|81173400|Non-Hodgkin Lymphoma|2002
0-14|0.5|0.6|0.6|342|Mortality|60563030|Other|2002
0-19|0.6|0.7|0.6|490|Mortality|81173400|Other|2002
0-14|0.1|0.2|0.2|95|Mortality|60563030|Soft Tissue|2002
0-19|0.2|0.2|0.2|153|Mortality|81173400|Soft Tissue|2002
0-14|0.4|0.5|0.4|246|Mortality|60628650|Acute Lymphocytic|2003
0-19|0.4|0.4|0.4|328|Mortality|81425816|Acute Lymphocytic|2003
0-14|0.2|0.3|0.2|142|Mortality|60628650|Acute Myeloid|2003
0-19|0.2|0.3|0.3|207|Mortality|81425816|Acute Myeloid|2003
0-14|2.4|2.7|2.5|1543|Mortality|60628650|All Cancer Sites Combined|2003
0-19|2.6|2.9|2.7|2233|Mortality|81425816|All Cancer Sites Combined|2003
0-14|0.1|0.2|0.1|82|Mortality|60628650|Bones and Joints|2003
0-19|0.2|0.3|0.2|186|Mortality|81425816|Bones and Joints|2003
0-14|0.7|0.8|0.8|458|Mortality|60628650|Brain and Other Nervous System|2003
0-19|0.7|0.8|0.7|577|Mortality|81425816|Brain and Other Nervous System|2003
0-14|~|~|~|~|Mortality|60628650|Hodgkin Lymphoma|2003
0-19|0.0|0.0|0.0|21|Mortality|81425816|Hodgkin Lymphoma|2003
0-14|0.1|0.1|0.1|54|Mortality|60628650|Kidney and Renal Pelvis|2003
0-19|0.1|0.1|0.1|65|Mortality|81425816|Kidney and Renal Pelvis|2003
0-14|0.8|0.9|0.8|505|Mortality|60628650|Leukemia|2003
0-19|0.8|0.9|0.8|688|Mortality|81425816|Leukemia|2003
0-14|0.1|0.1|0.1|50|Mortality|60628650|Non-Hodgkin Lymphoma|2003
0-19|0.1|0.2|0.1|103|Mortality|81425816|Non-Hodgkin Lymphoma|2003
0-14|0.5|0.6|0.5|311|Mortality|60628650|Other|2003
0-19|0.5|0.6|0.6|447|Mortality|81425816|Other|2003
0-14|0.1|0.2|0.1|78|Mortality|60628650|Soft Tissue|2003
0-19|0.2|0.2|0.2|146|Mortality|81425816|Soft Tissue|2003
0-14|0.3|0.4|0.3|202|Mortality|60651802|Acute Lymphocytic|2004
0-19|0.3|0.4|0.4|295|Mortality|81754354|Acute Lymphocytic|2004
0-14|0.2|0.3|0.2|147|Mortality|60651802|Acute Myeloid|2004
0-19|0.2|0.3|0.3|211|Mortality|81754354|Acute Myeloid|2004
0-14|2.3|2.6|2.5|1492|Mortality|60651802|All Cancer Sites Combined|2004
0-19|2.6|2.8|2.7|2223|Mortality|81754354|All Cancer Sites Combined|2004
0-14|0.1|0.2|0.1|75|Mortality|60651802|Bones and Joints|2004
0-19|0.2|0.3|0.2|189|Mortality|81754354|Bones and Joints|2004
0-14|0.7|0.8|0.7|446|Mortality|60651802|Brain and Other Nervous System|2004
0-19|0.6|0.7|0.7|555|Mortality|81754354|Brain and Other Nervous System|2004
0-14|~|~|~|~|Mortality|60651802|Hodgkin Lymphoma|2004
0-19|0.0|0.0|0.0|23|Mortality|81754354|Hodgkin Lymphoma|2004
0-14|0.1|0.1|0.1|51|Mortality|60651802|Kidney and Renal Pelvis|2004
0-19|0.1|0.1|0.1|59|Mortality|81754354|Kidney and Renal Pelvis|2004
0-14|0.7|0.8|0.8|455|Mortality|60651802|Leukemia|2004
0-19|0.8|0.9|0.8|665|Mortality|81754354|Leukemia|2004
0-14|0.1|0.1|0.1|44|Mortality|60651802|Non-Hodgkin Lymphoma|2004
0-19|0.1|0.1|0.1|100|Mortality|81754354|Non-Hodgkin Lymphoma|2004
0-14|0.5|0.6|0.5|317|Mortality|60651802|Other|2004
0-19|0.5|0.6|0.6|468|Mortality|81754354|Other|2004
0-14|0.1|0.2|0.2|98|Mortality|60651802|Soft Tissue|2004
0-19|0.2|0.2|0.2|164|Mortality|81754354|Soft Tissue|2004
0-14|0.3|0.4|0.3|188|Mortality|60519046|Acute Lymphocytic|2005
0-19|0.3|0.4|0.3|267|Mortality|82005260|Acute Lymphocytic|2005
0-14|0.2|0.3|0.2|137|Mortality|60519046|Acute Myeloid|2005
0-19|0.2|0.3|0.3|212|Mortality|82005260|Acute Myeloid|2005
0-14|2.3|2.5|2.4|1452|Mortality|60519046|All Cancer Sites Combined|2005
0-19|2.5|2.8|2.7|2183|Mortality|82005260|All Cancer Sites Combined|2005
0-14|0.1|0.2|0.1|88|Mortality|60519046|Bones and Joints|2005
0-19|0.2|0.3|0.3|212|Mortality|82005260|Bones and Joints|2005
0-14|0.6|0.8|0.7|426|Mortality|60519046|Brain and Other Nervous System|2005
0-19|0.6|0.7|0.7|544|Mortality|82005260|Brain and Other Nervous System|2005
0-14|~|~|~|~|Mortality|60519046|Hodgkin Lymphoma|2005
0-19|0.0|0.0|0.0|22|Mortality|82005260|Hodgkin Lymphoma|2005
0-14|0.1|0.1|0.1|54|Mortality|60519046|Kidney and Renal Pelvis|2005
0-19|0.1|0.1|0.1|62|Mortality|82005260|Kidney and Renal Pelvis|2005
0-14|0.6|0.8|0.7|417|Mortality|60519046|Leukemia|2005
0-19|0.7|0.8|0.8|640|Mortality|82005260|Leukemia|2005
0-14|0.1|0.1|0.1|55|Mortality|60519046|Non-Hodgkin Lymphoma|2005
0-19|0.1|0.1|0.1|102|Mortality|82005260|Non-Hodgkin Lymphoma|2005
0-14|0.5|0.6|0.5|318|Mortality|60519046|Other|2005
0-19|0.5|0.6|0.5|438|Mortality|82005260|Other|2005
0-14|0.1|0.2|0.1|83|Mortality|60519046|Soft Tissue|2005
0-19|0.2|0.2|0.2|163|Mortality|82005260|Soft Tissue|2005
0-14|0.2|0.3|0.3|174|Mortality|60516709|Acute Lymphocytic|2006
0-19|0.3|0.4|0.3|266|Mortality|82324418|Acute Lymphocytic|2006
0-14|0.2|0.2|0.2|124|Mortality|60516709|Acute Myeloid|2006
0-19|0.2|0.3|0.2|195|Mortality|82324418|Acute Myeloid|2006
0-14|2.1|2.4|2.2|1360|Mortality|60516709|All Cancer Sites Combined|2006
0-19|2.4|2.6|2.5|2035|Mortality|82324418|All Cancer Sites Combined|2006
0-14|0.1|0.1|0.1|59|Mortality|60516709|Bones and Joints|2006
0-19|0.2|0.2|0.2|174|Mortality|82324418|Bones and Joints|2006
0-14|0.6|0.8|0.7|422|Mortality|60516709|Brain and Other Nervous System|2006
0-19|0.6|0.7|0.6|524|Mortality|82324418|Brain and Other Nervous System|2006
0-14|~|~|~|~|Mortality|60516709|Hodgkin Lymphoma|2006
0-19|0.0|0.0|0.0|23|Mortality|82324418|Hodgkin Lymphoma|2006
0-14|0.1|0.1|0.1|43|Mortality|60516709|Kidney and Renal Pelvis|2006
0-19|0.1|0.1|0.1|54|Mortality|82324418|Kidney and Renal Pelvis|2006
0-14|0.6|0.7|0.7|411|Mortality|60516709|Leukemia|2006
0-19|0.7|0.8|0.7|618|Mortality|82324418|Leukemia|2006
0-14|0.1|0.1|0.1|44|Mortality|60516709|Non-Hodgkin Lymphoma|2006
0-19|0.1|0.1|0.1|89|Mortality|82324418|Non-Hodgkin Lymphoma|2006
0-14|0.4|0.5|0.5|296|Mortality|60516709|Other|2006
0-19|0.5|0.6|0.5|413|Mortality|82324418|Other|2006
0-14|0.1|0.2|0.1|80|Mortality|60516709|Soft Tissue|2006
0-19|0.1|0.2|0.2|140|Mortality|82324418|Soft Tissue|2006
0-14|0.3|0.4|0.4|212|Mortality|60681615|Acute Lymphocytic|2007
0-19|0.3|0.4|0.4|294|Mortality|82749431|Acute Lymphocytic|2007
0-14|0.2|0.3|0.2|129|Mortality|60681615|Acute Myeloid|2007
0-19|0.2|0.3|0.2|195|Mortality|82749431|Acute Myeloid|2007
0-14|2.2|2.4|2.3|1395|Mortality|60681615|All Cancer Sites Combined|2007
0-19|2.4|2.6|2.5|2068|Mortality|82749431|All Cancer Sites Combined|2007
0-14|0.1|0.1|0.1|61|Mortality|60681615|Bones and Joints|2007
0-19|0.2|0.2|0.2|172|Mortality|82749431|Bones and Joints|2007
0-14|0.6|0.8|0.7|426|Mortality|60681615|Brain and Other Nervous System|2007
0-19|0.6|0.7|0.6|521|Mortality|82749431|Brain and Other Nervous System|2007
0-14|~|~|~|~|Mortality|60681615|Hodgkin Lymphoma|2007
0-19|0.0|0.0|0.0|19|Mortality|82749431|Hodgkin Lymphoma|2007
0-14|0.0|0.1|0.1|36|Mortality|60681615|Kidney and Renal Pelvis|2007
0-19|0.0|0.1|0.1|47|Mortality|82749431|Kidney and Renal Pelvis|2007
0-14|0.7|0.8|0.7|441|Mortality|60681615|Leukemia|2007
0-19|0.7|0.8|0.8|643|Mortality|82749431|Leukemia|2007
0-14|0.0|0.1|0.1|40|Mortality|60681615|Non-Hodgkin Lymphoma|2007
0-19|0.1|0.1|0.1|87|Mortality|82749431|Non-Hodgkin Lymphoma|2007
0-14|0.4|0.6|0.5|306|Mortality|60681615|Other|2007
0-19|0.5|0.6|0.5|439|Mortality|82749431|Other|2007
0-14|0.1|0.2|0.1|82|Mortality|60681615|Soft Tissue|2007
0-19|0.1|0.2|0.2|140|Mortality|82749431|Soft Tissue|2007
0-14|0.3|0.3|0.3|879|Mortality|305053166|Acute Lymphocytic|2007-2011
0-19|0.3|0.3|0.3|1240|Mortality|415152308|Acute Lymphocytic|2007-2011
0-14|0.2|0.2|0.2|623|Mortality|305053166|Acute Myeloid|2007-2011
0-19|0.2|0.2|0.2|932|Mortality|415152308|Acute Myeloid|2007-2011
0-14|2.1|2.2|2.2|6676|Mortality|305053166|All Cancer Sites Combined|2007-2011
0-19|2.3|2.4|2.4|9918|Mortality|415152308|All Cancer Sites Combined|2007-2011
0-14|0.1|0.1|0.1|348|Mortality|305053166|Bones and Joints|2007-2011
0-19|0.2|0.2|0.2|873|Mortality|415152308|Bones and Joints|2007-2011
0-14|0.7|0.7|0.7|2106|Mortality|305053166|Brain and Other Nervous System|2007-2011
0-19|0.6|0.7|0.6|2624|Mortality|415152308|Brain and Other Nervous System|2007-2011
0-14|~|~|~|~|Mortality|305053166|Hodgkin Lymphoma|2007-2011
0-19|0.0|0.0|0.0|84|Mortality|415152308|Hodgkin Lymphoma|2007-2011
0-14|0.1|0.1|0.1|205|Mortality|305053166|Kidney and Renal Pelvis|2007-2011
0-19|0.1|0.1|0.1|245|Mortality|415152308|Kidney and Renal Pelvis|2007-2011
0-14|0.6|0.7|0.6|1964|Mortality|305053166|Leukemia|2007-2011
0-19|0.7|0.7|0.7|2874|Mortality|415152308|Leukemia|2007-2011
0-14|0.1|0.1|0.1|184|Mortality|305053166|Non-Hodgkin Lymphoma|2007-2011
0-19|0.1|0.1|0.1|394|Mortality|415152308|Non-Hodgkin Lymphoma|2007-2011
0-14|0.4|0.5|0.5|1422|Mortality|305053166|Other|2007-2011
0-19|0.5|0.5|0.5|2066|Mortality|415152308|Other|2007-2011
0-14|0.1|0.2|0.1|432|Mortality|305053166|Soft Tissue|2007-2011
0-19|0.2|0.2|0.2|758|Mortality|415152308|Soft Tissue|2007-2011
0-14|0.2|0.3|0.3|176|Mortality|60907384|Acute Lymphocytic|2008
0-19|0.3|0.3|0.3|253|Mortality|83118264|Acute Lymphocytic|2008
0-14|0.2|0.2|0.2|127|Mortality|60907384|Acute Myeloid|2008
0-19|0.2|0.3|0.2|183|Mortality|83118264|Acute Myeloid|2008
0-14|2.1|2.3|2.2|1354|Mortality|60907384|All Cancer Sites Combined|2008
0-19|2.3|2.5|2.4|2039|Mortality|83118264|All Cancer Sites Combined|2008
0-14|0.1|0.1|0.1|62|Mortality|60907384|Bones and Joints|2008
0-19|0.2|0.2|0.2|182|Mortality|83118264|Bones and Joints|2008
0-14|0.6|0.8|0.7|429|Mortality|60907384|Brain and Other Nervous System|2008
0-19|0.6|0.7|0.6|533|Mortality|83118264|Brain and Other Nervous System|2008
0-14|~|~|~|~|Mortality|60907384|Hodgkin Lymphoma|2008
0-19|~|~|~|~|Mortality|83118264|Hodgkin Lymphoma|2008
0-14|0.1|0.1|0.1|46|Mortality|60907384|Kidney and Renal Pelvis|2008
0-19|0.0|0.1|0.1|52|Mortality|83118264|Kidney and Renal Pelvis|2008
0-14|0.6|0.7|0.7|402|Mortality|60907384|Leukemia|2008
0-19|0.7|0.8|0.7|598|Mortality|83118264|Leukemia|2008
0-14|0.0|0.1|0.1|39|Mortality|60907384|Non-Hodgkin Lymphoma|2008
0-19|0.1|0.1|0.1|93|Mortality|83118264|Non-Hodgkin Lymphoma|2008
0-14|0.4|0.5|0.5|286|Mortality|60907384|Other|2008
0-19|0.4|0.5|0.5|407|Mortality|83118264|Other|2008
0-14|0.1|0.2|0.1|89|Mortality|60907384|Soft Tissue|2008
0-19|0.2|0.2|0.2|160|Mortality|83118264|Soft Tissue|2008
0-14|0.2|0.3|0.3|174|Mortality|61087581|Acute Lymphocytic|2009
0-19|0.3|0.3|0.3|240|Mortality|83280391|Acute Lymphocytic|2009
0-14|0.2|0.2|0.2|119|Mortality|61087581|Acute Myeloid|2009
0-19|0.2|0.3|0.2|182|Mortality|83280391|Acute Myeloid|2009
0-14|2.0|2.3|2.2|1320|Mortality|61087581|All Cancer Sites Combined|2009
0-19|2.2|2.5|2.3|1964|Mortality|83280391|All Cancer Sites Combined|2009
0-14|0.1|0.2|0.1|77|Mortality|61087581|Bones and Joints|2009
0-19|0.2|0.2|0.2|179|Mortality|83280391|Bones and Joints|2009
0-14|0.6|0.7|0.7|402|Mortality|61087581|Brain and Other Nervous System|2009
0-19|0.6|0.7|0.6|522|Mortality|83280391|Brain and Other Nervous System|2009
0-14|~|~|~|~|Mortality|61087581|Hodgkin Lymphoma|2009
0-19|0.0|0.0|0.0|22|Mortality|83280391|Hodgkin Lymphoma|2009
0-14|0.0|0.1|0.1|38|Mortality|61087581|Kidney and Renal Pelvis|2009
0-19|0.0|0.1|0.1|45|Mortality|83280391|Kidney and Renal Pelvis|2009
0-14|0.6|0.7|0.6|389|Mortality|61087581|Leukemia|2009
0-19|0.6|0.7|0.7|561|Mortality|83280391|Leukemia|2009
0-14|0.0|0.1|0.1|38|Mortality|61087581|Non-Hodgkin Lymphoma|2009
0-19|0.1|0.1|0.1|75|Mortality|83280391|Non-Hodgkin Lymphoma|2009
0-14|0.4|0.5|0.4|271|Mortality|61087581|Other|2009
0-19|0.4|0.5|0.5|396|Mortality|83280391|Other|2009
0-14|0.1|0.2|0.2|98|Mortality|61087581|Soft Tissue|2009
0-19|0.2|0.2|0.2|164|Mortality|83280391|Soft Tissue|2009
0-14|0.2|0.3|0.3|164|Mortality|61201748|Acute Lymphocytic|2010
0-19|0.2|0.3|0.3|230|Mortality|83180982|Acute Lymphocytic|2010
0-14|0.2|0.3|0.2|131|Mortality|61201748|Acute Myeloid|2010
0-19|0.2|0.3|0.2|198|Mortality|83180982|Acute Myeloid|2010
0-14|2.0|2.3|2.2|1324|Mortality|61201748|All Cancer Sites Combined|2010
0-19|2.2|2.4|2.3|1925|Mortality|83180982|All Cancer Sites Combined|2010
0-14|0.1|0.2|0.1|75|Mortality|61201748|Bones and Joints|2010
0-19|0.2|0.2|0.2|166|Mortality|83180982|Bones and Joints|2010
0-14|0.6|0.7|0.7|410|Mortality|61201748|Brain and Other Nervous System|2010
0-19|0.6|0.7|0.6|498|Mortality|83180982|Brain and Other Nervous System|2010
0-14|~|~|~|~|Mortality|61201748|Hodgkin Lymphoma|2010
0-19|~|~|~|~|Mortality|83180982|Hodgkin Lymphoma|2010
0-14|0.1|0.1|0.1|46|Mortality|61201748|Kidney and Renal Pelvis|2010
0-19|0.1|0.1|0.1|56|Mortality|83180982|Kidney and Renal Pelvis|2010
0-14|0.6|0.7|0.6|390|Mortality|61201748|Leukemia|2010
0-19|0.6|0.7|0.7|553|Mortality|83180982|Leukemia|2010
0-14|0.0|0.1|0.1|35|Mortality|61201748|Non-Hodgkin Lymphoma|2010
0-19|0.1|0.1|0.1|75|Mortality|83180982|Non-Hodgkin Lymphoma|2010
0-14|0.4|0.5|0.5|286|Mortality|61201748|Other|2010
0-19|0.5|0.6|0.5|419|Mortality|83180982|Other|2010
0-14|0.1|0.2|0.1|79|Mortality|61201748|Soft Tissue|2010
0-19|0.1|0.2|0.2|146|Mortality|83180982|Soft Tissue|2010
0-14|0.2|0.3|0.3|153|Mortality|61174838|Acute Lymphocytic|2011
0-19|0.2|0.3|0.3|223|Mortality|82823240|Acute Lymphocytic|2011
0-14|0.2|0.2|0.2|117|Mortality|61174838|Acute Myeloid|2011
0-19|0.2|0.2|0.2|174|Mortality|82823240|Acute Myeloid|2011
0-14|2.0|2.2|2.1|1283|Mortality|61174838|All Cancer Sites Combined|2011
0-19|2.2|2.4|2.3|1922|Mortality|82823240|All Cancer Sites Combined|2011
0-14|0.1|0.2|0.1|73|Mortality|61174838|Bones and Joints|2011
0-19|0.2|0.2|0.2|174|Mortality|82823240|Bones and Joints|2011
0-14|0.7|0.8|0.7|439|Mortality|61174838|Brain and Other Nervous System|2011
0-19|0.6|0.7|0.7|550|Mortality|82823240|Brain and Other Nervous System|2011
0-14|~|~|~|~|Mortality|61174838|Hodgkin Lymphoma|2011
0-19|0.0|0.0|0.0|17|Mortality|82823240|Hodgkin Lymphoma|2011
0-14|0.0|0.1|0.1|39|Mortality|61174838|Kidney and Renal Pelvis|2011
0-19|0.0|0.1|0.1|45|Mortality|82823240|Kidney and Renal Pelvis|2011
0-14|0.5|0.6|0.6|342|Mortality|61174838|Leukemia|2011
0-19|0.6|0.7|0.6|519|Mortality|82823240|Leukemia|2011
0-14|0.0|0.1|0.1|32|Mortality|61174838|Non-Hodgkin Lymphoma|2011
0-19|0.1|0.1|0.1|64|Mortality|82823240|Non-Hodgkin Lymphoma|2011
0-14|0.4|0.5|0.4|273|Mortality|61174838|Other|2011
0-19|0.4|0.5|0.5|405|Mortality|82823240|Other|2011
0-14|0.1|0.2|0.1|84|Mortality|61174838|Soft Tissue|2011
0-19|0.1|0.2|0.2|148|Mortality|82823240|Soft Tissue|2011